Description

The Human BTLA / HVEM Binding Assay Kit uses a rapid, simple, and sensitive method to characterize the binding affinity between herpes virus entry mediator and its receptor B- and T-lymphocyte attenuator in the presence of potential inhibitors within 4 hours. 4-8 week development phase.